Galanin Receptors as Drug Target for Novel Antidepressants: Review

References

• Melander T, Hökfelt T, Rökaeus A. Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol. 1986;248(4):475–517. doi:10.1002/cne.v248:42424949
   PubMedGoogle Scholar
• Fuxe K, Agnati LF, Von Euler G, et al. Galanin/5-HT receptor interactions. A new integrative mechanism in the control of 5-HT neurotransmission in the central nervous system In: Paoletti R,Vonhoutte PM,Brunello N, Maggi FM, editors. Serotonin. Dordrecht: Springer; 1990:169–185.
   Google Scholar
• Xu IS, Grass S, Xu XJ, Wiesenfeld-Hallin Z. On the role of galanin in mediating spinal flexor reflex excitability in inflammation. Neurosci. 1998;85(3):827–835. doi:10.1016/S0306-4522(97)00676-3
   Google Scholar
• Lu X, Barr AM, Kinney JW, et al. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci. 2005;102(3):874–879. doi:10.1073/pnas.040889110215647369
   PubMedGoogle Scholar
• Kask K, Langel Ü, Bartfai T. Galanin—a neuropeptide with inhibitory actions. Cell Mol Neurobiol. 1995;15(6):653–673. doi:10.1007/BF020711308719035
   PubMedGoogle Scholar
• Lundkvist J, Land T, Kahl U, Bedecs K, Bartfai T. cDNA sequence, ligand binding, and regulation of galanin/GMAP in mouse brain. Neurosci Lett. 1995;200(2):121–124. doi:10.1016/0304-3940(95)12094-K8614559
   PubMed Web of Science ®Google Scholar
• Kakuyama H, Kuwahara A, Mochizuki T, Hoshino M, Yanaihara N. Role of N-terminal active sites of galanin in neurally evoked circular muscle contractions in the guinea-pig ileum. Eur J Pharmacol. 1997;329(1):85–91. doi:10.1016/S0014-2999(97)10109-19218688
   PubMed Web of Science ®Google Scholar
• Smith KE, Walker MW, Artymyshyn R, et al. Cloned human and rat galanin GALR3 receptors pharmacology and activation of G-protein inwardly rectifying K+ channels. J Biol Chem. 1998;273(36):23321–23326. doi:10.1074/jbc.273.36.233219722565
   PubMed Web of Science ®Google Scholar
• Lang R, Gundlach AL, Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther. 2007;115(2):177–207. doi:10.1016/j.pharmthera.2007.05.00917604107
   PubMed Web of Science ®Google Scholar
• Ögren SO, Kuteeva E, Elvander-Tottie E, Hökfelt T. Neuropeptides in learning and memory processes with focus on galanin. Eur J Pharmacol. 2010;626(1):9–17. doi:10.1016/j.ejphar.2009.09.07019837050
   PubMed Web of Science ®Google Scholar
• Picciotto MR, Brabant C, Einstein EB, Kamens HM, Neugebauer NM. Effects of galanin on monoaminergic systems and HPA axis: potential mechanisms underlying the effects of galanin on addiction-and stress-related behaviors. Brain Res. 2010;1314:206–218.19699187
   PubMed Web of Science ®Google Scholar
• Smith KE, Forray C, Walker MW, et al. Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover. J Biol Chem. 1997;272(39):24612–24616. doi:10.1074/jbc.272.39.246129305929
   PubMed Web of Science ®Google Scholar
• Smith KE, Walker MW, Artymyshyn R, et al. Cloned human and rat galanin GALR3 receptors Pharmacology and activation of G-protein inwardly rectifying K+ channels. Journal of Biological Chemistry. 1998;273(36):23321-23326.9722565
   PubMed Web of Science ®Google Scholar
• Iismaa TP, Shine J. Galanin and galanin receptors In:Richter D, editor. Regulatory Peptides and Cognate Receptors. Berlin, Heidelberg: Springer; 1999;26:257–291.
   Google Scholar
• Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF. Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci. 1994;91(21):9780–9783. doi:10.1073/pnas.91.21.97807524088
   PubMed Web of Science ®Google Scholar
• Juhasz G, Hullam G, Eszlari N, et al. Brain galanin system genes interact with life stresses in depression-related phenotypes. Proc Natl Acad Sci. 2014;111(16):E1666–73. doi:10.1073/pnas.140364911124706871
   PubMedGoogle Scholar
• Saar I, Lahe J, Langel K, et al. Novel systemically active galanin receptor 2 ligands in depression‐like behavior. J Neurochem. 2013;127(1):114–123. doi:10.1111/jnc.1227423600864
   PubMed Web of Science ®Google Scholar
• Crawley JN, Wenk GL. Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia? Trends Neurosci. 1989;12(8):278–282. doi:10.1016/0166-2236(89)90003-92475942
   PubMedGoogle Scholar
• Dunne MJ, Bullett MJ, Li GD, Wollheim CB, Petersen OH. Galanin activates nucleotide‐dependent K+ channels in insulin‐secreting cells via a pertussis toxin‐sensitive G‐protein. EMBO J. 1989;8(2):413–420. doi:10.1002/embj.1989.8.issue-22470586
   PubMed Web of Science ®Google Scholar
• Fridolf T, Ahrén B. Dual action of the neuropeptide galanin on the cytoplasmic free calcium concentration in RIN m5F cells. Biochem Biophys Res Commun. 1993;191(3):1224–1229. doi:10.1006/bbrc.1993.13487682064
   PubMedGoogle Scholar
• Jurkowski W, Yazdi S, Elofsson A. Ligand binding properties of human galanin receptors. Mol Membr Biol. 2013;30(2):206–216. doi:10.3109/09687688.2012.75038423237663
   PubMed Web of Science ®Google Scholar
• Guipponi M, Chentouf A, Webling KE, et al. Galanin pathogenic mutations in temporal lobe epilepsy. Hum Mol Genet. 2015;24(11):3082–3091.25691535
   PubMed Web of Science ®Google Scholar
• Wang P, Li H, Barde S, et al. Depression-like behavior in rat: involvement of galanin receptor subtype 1 in the ventral periaqueductal gray. Proc Natl Acad Sci. 2016;113(32):E4726–35. doi:10.1073/pnas.160919811327457954
   PubMedGoogle Scholar
• Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 1992;11(1):1–20. doi:10.1089/dna.1992.11.11310857
   PubMedGoogle Scholar
• Krishna AG, Menon ST, Terry TJ, Sakmar TP. Evidence that helix 8 of rhodopsin acts as a membrane-dependent conformational switch. Biochemistry. 2002;41(26):8298–8309. doi:10.1021/bi025534m12081478
   PubMedGoogle Scholar
• Burbach JP. Neuropeptides from concept to online database www.neuropeptides.nl. Eur J Pharmacol. 2010;626(1):27–48. doi:10.1016/j.ejphar.2009.10.01519837055
   PubMed Web of Science ®Google Scholar
• Wang S, He C, Maguire MT, et al. Genomic organization and functional characterization of the mouse GalR1 galanin receptor. FEBS Lett. 1997;411(2–3):225–230. doi:10.1016/S0014-5793(97)00695-99271210
   PubMedGoogle Scholar
• Pang L, Hashemi T, Lee HJ, et al. The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization. J Neurochem. 1998;71(6):2252–2259. doi:10.1046/j.1471-4159.1998.71062252.x9832122
   PubMedGoogle Scholar
• Pan J, Singh US, Takahashi T, et al. PKC mediates cyclic stretch‐induced cardiac hypertrophy through Rho family GTPases and mitogen‐activated protein kinases in cardiomyocytes. J Cell Physiol. 2005;202(2):536–553. doi:10.1002/jcp.2015115316932
   PubMedGoogle Scholar
• Mons N, Decorte L, Jaffard R, Cooper DM. Ca2+-sensitive adenylyl cyclases, key integrators of cellular signalling. Life Sci. 1998;62(17–18):1647–1652. doi:10.1016/S0024-3205(98)00122-29585151
   PubMedGoogle Scholar
• Wang S, Hashemi T, Fried S, Clemmons AL, Hawes BE. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry. 1998;37(19):6711–6717. doi:10.1021/bi97284059578554
   PubMed Web of Science ®Google Scholar
• Kolakowski LF Jr, O’Neill GP, Howard AD, et al. Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J Neurochem. 2002;71(6):2239–2251. doi:10.1046/j.1471-4159.1998.71062239.x
   Google Scholar
• Charney DS, Manji HK. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci Stke. 2004;2004(225):re5.15039492
   PubMedGoogle Scholar
• Rang HP, Ritter JM, Flower RJ, Henderson G. Rang and Dale’s Pharmacology. 8th ed. Churchill Livingstone; 2015.
   Google Scholar
• Kendler KS. The dappled nature of causes of psychiatric illness: replacing the organic–functional/hardware–software dichotomy with empirically based pluralism. Mol Psychiatry. 2012;17(4):377–388. doi:10.1038/mp.2011.18222230881
   PubMed Web of Science ®Google Scholar
• Liu M, Simon MI. Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C. Nature. 1996;382(6586):83–87. doi:10.1038/382083a08657310
   PubMedGoogle Scholar
• Tatemoto K, Rökaeus Å, Jörnvall H, McDonald TJ, Mutt V. Galanin—a novel biologically active peptide from porcine intestine. FEBS Lett. 1983;164(1):124–128. doi:10.1016/0014-5793(83)80033-76197320
   PubMed Web of Science ®Google Scholar
• Katzung BG. Basic and Clinical Pharmacology. Mc Graw Hill; 2012.
   Google Scholar
• Morilak DA, Frazer A. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol. 2004;7(2):193–218. doi:10.1017/S146114570400408015003145
   PubMedGoogle Scholar
• Millan MJ. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther. 2006;110(2):135–370. doi:10.1016/j.pharmthera.2005.11.00616522330
   PubMed Web of Science ®Google Scholar
• Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology. 2012;20(3):127–150.22271002
   PubMedGoogle Scholar
• Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28–40. doi:10.1176/appi.ajp.163.1.2816390886
   PubMed Web of Science ®Google Scholar
• Diaz-Cabiale Z, Parrado C, Fuxe K, Agnati L, Narvaez JA. Receptor–receptor interactions in central cardiovascular regulation. Focus on neuropeptide/α 2-adrenoreceptor interactions in the nucleus tractus solitarius. J Neural Transm. 2007;114(1):115–125. doi:10.1007/s00702-006-0559-616988794
   PubMedGoogle Scholar
• Díaz-Cabiale Z, Parrado C, Narváez M, et al. Neurochemical modulation of central cardiovascular control: the integrative role of galanin In: Hokfelt T, editor. Galanin. Basel: Springer; 2010;102:113–131.
   Google Scholar
• Díaz-Cabiale Z, Parrado C, Narváez M, et al. Galanin receptor/neuropeptide Y receptor interactions in the dorsal raphe nucleus of the rat. Neuropharmacol. 2011;61(1–2):80–86. doi:10.1016/j.neuropharm.2011.03.002
   PubMedGoogle Scholar
• Millón C, Flores-Burgess A, Narváez M, et al. A role for galanin N-terminal fragment (1–15) in anxiety-and depression-related behaviors in rats. Int J Neuropsychopharmacol. 2015;18(3):pyu064. doi:10.1093/ijnp/pyu064
   Google Scholar
• Weiss JM, Bonsall RW, Demetrikopoulos MK, Emery MS, West CH. Galanin: a significant role in depression? Ann N Y Acad Sci. 1998;863(1):364–382. doi:10.1111/j.1749-6632.1998.tb10707.x9928183
   PubMedGoogle Scholar
• Millón C, Flores-Burgess A, Narváez M, et al. (1–15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system. Brain Struct Funct. 2016;221(9):4491–4504. doi:10.1007/s00429-015-1180-y26792005
   PubMedGoogle Scholar
• Jackowski A, Crockard A, Burnstock G, Lincoln J. Alterations in serotonin and neuropeptide Y content of cerebrovascular sympathetic nerves following experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1989;9(3):271–279. doi:10.1038/jcbfm.1989.452497110
   PubMedGoogle Scholar
• Terenina NB, Kreshchenko ND, Mochalova NB, Movsesyan SO. Serotonin and neuropeptide FMRFamide in the attachment organs of trematodes. Helminthologia. 2018;55(3):185–194. doi:10.2478/helm-2018-002231662646
   PubMedGoogle Scholar
• Bai YF, Ma HT, Liu LN, et al. Activation of galanin receptor 1 inhibits locus coeruleus neurons via GIRK channels. Biochem Biophys Res Commun. 2018;503(1):79–85. doi:10.1016/j.bbrc.2018.05.18129852172
   PubMed Web of Science ®Google Scholar
• Morais JS, Souza MM, Campanha TM, et al. Galanin subtype 1 and subtype 2 receptors mediate opposite anxiety-like effects in the rat dorsal raphe nucleus. Behav Brain Res. 2016;314:125–133. doi:10.1016/j.bbr.2016.08.00727498247
   PubMedGoogle Scholar
• Razani H, Diaz-Cabiale Z, Fuxe K, Ögren SO. Intraventricular galanin produces a time-dependent modulation of 5-HT1A receptors in the dorsal raphe of the rat. Neuroreport. 2000;11(18):3943–3948. doi:10.1097/00001756-200012180-0000811192606
   PubMed Web of Science ®Google Scholar
• Lang R, Gundlach AL, Holmes FE, et al. Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity. Pharmacol Rev. 2015;67(1):118–175.25428932
   PubMed Web of Science ®Google Scholar
• Fuxe K, Ögren SO, Jansson A, Cintra A, Härfstrand A, Agnati LF. Intraventricular injections of galanin reduces 5‐HT metabolism in the ventral limbic cortex, the hippocampal formation and the fronto‐parietal cortex of the male rat. Acta Physiol Scand. 1988;133(4):579–581. doi:10.1111/j.1748-1716.1988.tb08444.x2465672
   PubMedGoogle Scholar
• Hedlund PB, Galanin FK. 5‐HT1A Receptor interactions as an integrative mechanism in 5‐HT neurotransmission in the brain a. Ann N Y Acad Sci. 1996;780(1):193–212. doi:10.1111/j.1749-6632.1996.tb15124.x8602734
   PubMedGoogle Scholar
• Kehr J, Yoshitake T, Wang FH, et al. Galanin is a potent in vivo modulator of mesencephalic serotonergic neurotransmission. Neuropsychopharmacol. 2002;27(3):341–356. doi:10.1016/S0893-133X(02)00309-3
   PubMedGoogle Scholar
• Misane I, Razani H, Jansson FH, Fuxe K, Ögren SO. Intraventricular galanin modulates a 5‐HT1A receptor‐mediated behavioural response in the rat. Eur J Neurosci. 1998;10(4):1230–1240. doi:10.1046/j.1460-9568.1998.00132.x9749777
   PubMed Web of Science ®Google Scholar
• Razani H, Díaz-Cabiale Z, Misane I, Wang FH, Fuxe K, Ögren SO. Prolonged effects of intraventricular galanin on a 5-hydroxytryptamine1A receptor mediated function in the rat. Neurosci Lett. 2001;299(1–2):145–149. doi:10.1016/S0304-3940(00)01788-211166958
   PubMedGoogle Scholar
• Parker EM, Izzarelli DG, Nowak HP, et al. Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells. Mol Brain Res. 1995;34(2):179–189. doi:10.1016/0169-328X(95)00159-P8750821
   PubMedGoogle Scholar
• Bartfai T, Lu X, Badie-Mahdavi H, et al. Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci. 2004;101(28):10470–10475. doi:10.1073/pnas.040380210115240875
   PubMed Web of Science ®Google Scholar
• Kuteeva E, Hökfelt T, Wardi T, Ogren SO. Galanin, galanin receptor subtypes and depression-like behaviour. Cell Mol Life Sci CMLS. 2008;65(12):1854–1863. doi:10.1007/s00018-008-8160-918500640
   PubMedGoogle Scholar
• Hedlund P, Von Euler G, Fuxe K. Activation of 5-hydroxytryptamine1A receptors increases the affinity of galanin receptors in di-and telencephalic areas of the rat. Brain Res. 1991;560(1–2):251–259. doi:10.1016/0006-8993(91)91240-21836971
   PubMedGoogle Scholar
• Borroto-Escuela DO, Narvaez M, Marcellino D, et al. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochem Biophys Res Commun. 2010;393(4):767–772. doi:10.1016/j.bbrc.2010.02.07820171159
   PubMed Web of Science ®Google Scholar
• Mennicken F, Hoffert C, Pelletier M, Ahmad S, O’Donnell D. Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J Chem Neuroanat. 2002;24(4):257–268. doi:10.1016/S0891-0618(02)00068-612406501
   PubMed Web of Science ®Google Scholar
• Yoshitake S, Kuteeva E, Hökfelt T, et al. Correlation between the effects of local and intracerebroventricular infusions of galanin on 5‐HT release studied by microdialysis, and distribution of galanin and galanin receptors in prefrontal cortex, ventral hippocampus, amygdala, hypothalamus, and striatum of awake rats. Synapse. 2014;68(5):179–193. doi:10.1002/syn.2173024430888
   PubMedGoogle Scholar
• HöKFELT TO, ZQ XU, SHI TJ, Holmberg K, Zhang X. Galanin in ascending systems: focus on coexistence with 5‐hydroxytryptamine and noradrenaline a. Ann N Y Acad Sci. 1998;863(1):252–263. doi:10.1111/j.1749-6632.1998.tb10700.x9928176
   PubMedGoogle Scholar
• Seutin V, Verbanck P, Massotte L, Dresse A. Galanin decreases the activity of locus coeruleus neurons in vitro. Eur J Pharmacol. 1989;164(2):373–376. doi:10.1016/0014-2999(89)90481-02474450
   PubMed Web of Science ®Google Scholar
• Hökfelt T, Broberger C, Diez M, et al. NPY, two peptides with multiple putative roles in the nervous system. Horm Metab Res. 1999;31(5):330–334. doi:10.1055/s-2007-97874810422730
   PubMed Web of Science ®Google Scholar
• Ma X, Tong YG, Schmidt R, et al. Effects of galanin receptor agonists on locus coeruleus neurons. Brain Res. 2001;919(1):169–174. doi:10.1016/S0006-8993(01)03033-511689176
   PubMedGoogle Scholar
• Pieribone VA, Xu ZQ, Zhang X, Grillner S, Bartfai T, Hökfelt T. Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice. Neurosci. 1995;64(4):861–874. doi:10.1016/0306-4522(94)00450-J
   PubMed Web of Science ®Google Scholar
• Millón C, Flores-Burgess A, Narváez M, et al. The neuropeptides galanin and galanin (1–15) in depression-like behaviours. Neuropeptides. 2017;64:39–45. doi:10.1016/j.npep.2017.01.00428196617
   PubMedGoogle Scholar
• Borroto-Escuela DO, Narvaez M, Di Palma M, et al. Preferential activation by galanin 1–15 fragment of the GalR1 protomer of a GalR1–GalR2 heteroreceptor complex. Biochem Biophys Res Commun. 2014;452(3):347–353. doi:10.1016/j.bbrc.2014.08.06125152404
   PubMedGoogle Scholar
• Díaz‐Cabiale Z, Parrado C, Rivera A, et al. (NPY) interactions in central cardiovascular control: involvement of the NPY Y1 receptor subtype. Eur J Neurosci. 2006;24(2):499–508. doi:10.1111/j.1460-9568.2006.04937.x16903855
   PubMedGoogle Scholar
• Fuxe K, Marcellino D, Rivera A, et al. Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev. 2008;58(2):415–452. doi:10.1016/j.brainresrev.2007.11.00718222544
   PubMedGoogle Scholar
• Branchek TA, Smith KE, Gerald C, Walker MW. Galanin receptor subtypes. Trends Pharmacol Sci. 2000;21(3):109–117. doi:10.1016/S0165-6147(00)01446-210689365
   PubMed Web of Science ®Google Scholar
• Narváez M, Borroto-Escuela DO, Millón C, et al. Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects. Brain Struct Funct. 2016;221(8):4129–4139. doi:10.1007/s00429-015-1153-126666529
   PubMedGoogle Scholar
• Narváez M, Borroto-Escuela DO, Santín L, et al. A novel integrative mechanism in anxiolytic behavior induced by galanin 2/neuropeptide Y Y1 receptor interactions on medial paracapsular intercalated amygdala in rats. Front Cell Neurosci. 2018;1(12):119. doi:10.3389/fncel.2018.00119
   Google Scholar
• Díaz-Cabiale Z, Flores-Burgess A, Parrado C, et al. Galanin receptor/neuropeptide y receptor interactions in the central nervous system. Curr Protein Pept Sci. 2014;15(7):666–672. doi:10.2174/138920371566614090111170925175455
   PubMedGoogle Scholar
• Kummer W. Galanin-and neuropeptide Y-like immunoreactivities coexist in paravertebral sympathetic neurones of the cat. Neurosci Lett. 1987;78(2):127–131. doi:10.1016/0304-3940(87)90620-32442671
   PubMedGoogle Scholar
• Flores-Burgess A, Millón C, Gago B, et al. (1–15) enhancement of the behavioral effects of fluoxetine in the forced swimming test gives a new therapeutic strategy against depression. Neuropharmacol. 2017;118:233–241. doi:10.1016/j.neuropharm.2017.03.010
   PubMedGoogle Scholar
• Borroto-Escuela DO, Li X, Tarakanov AO, et al. Existence of brain 5-HT1A–5-HT2A isoreceptor complexes with antagonistic allosteric receptor–receptor interactions regulating 5-HT1A receptor recognition. ACS Omega. 2017;2(8):4779–4789. doi:10.1021/acsomega.7b0062928920103
   PubMedGoogle Scholar
• Borroto-Escuela DO, Narváez M, Ambrogini P, et al. Receptor–receptor interactions in multiple 5-HT1A heteroreceptor complexes in raphe-hippocampal 5-HT transmission and their relevance for depression and its treatment. Mol. 2018;23(6):1341. doi:10.3390/molecules23061341
   PubMedGoogle Scholar
• Flores-Burgess A, Millón C, Gago B, et al. (1–15)-fluoxetine interaction in the novel object recognition test. Involvement of 5-HT1A receptors in the prefrontal cortex of the rats. Neuropharmacol. 2019;155:104–112. doi:10.1016/j.neuropharm.2019.05.023
   PubMedGoogle Scholar
• de Souza MM, Silote GP, Herbst LS, Funck VR, Joca SRL, Beijamini V. The antidepressant-like effect of galanin in the dorsal raphe nucleus of rats involves GAL(2) receptors. Neurosci Lett. 2018;681:26–30. doi:10.1016/j.neulet.2018.05.029.29787787
   PubMedGoogle Scholar